RAPT Therapeutics, Inc. Income Statement

Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 5.04M3.81M1.53M
Gross Profit 5.04M3.81M1.53M
Operating items
Research & Development 31.77M34.91M45.48M56.98M67.08M101.00M
Selling, General & Administrative 5.18M8.72M12.77M16.04M20.24M26.06M
Operating Expenses 36.95M43.63M58.26M73.02M87.32M127.06M
Operating Income -36.95M-43.63M-53.21M-69.21M-85.80M-127.06M
EBIT -36.95M-43.63M-53.21M-69.21M-85.80M-127.06M
Non-operating items
Non Operating Income 0.80M1.29M1.31M0.01M1.96M10.26M
Net income details
EBT -36.15M-42.34M-51.90M-69.20M-85.80M-127.06M
Tax Provisions 0.66M0.99M
Profit After Tax -36.15M-43.00M-52.89M-69.20M-83.84M-116.80M
Income from Continuing Operations -36.15M-43.00M-52.89M-69.20M-85.80M-127.06M
Consolidated Net Income -36.15M-43.00M-52.89M-69.20M-85.80M-127.06M
Income towards Parent Company -36.15M-43.00M-52.89M-69.20M-85.80M-127.06M
Net Income towards Common Stockholders -36.15M-43.00M-52.89M-69.20M-85.80M-127.06M
Additional items
EPS (Basic) 0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 2.66M2.73M3.07M3.69M3.74M4.30M4.37M
Shares Outstanding (Diluted Average) 27.39M32.54M38.34M
EBITDA -36.15M-42.97M-53.09M-69.23M-83.66M-116.67M